{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:26:39Z","timestamp":1786112799570,"version":"build-2736575974"},"reference-count":97,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["029GJHZ2024057GC"],"award-info":[{"award-number":["029GJHZ2024057GC"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["W2512066"],"award-info":[{"award-number":["W2512066"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82550005"],"award-info":[{"award-number":["82550005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.drudis.2026.104665","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T16:50:50Z","timestamp":1775667050000},"page":"104665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cognition-enhancing drugs: current landscape, mechanisms, and future prospects"],"prefix":"10.1016","volume":"31","author":[{"given":"Mengyuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2026.104665_b0005","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/1529100620920576","article-title":"Education and cognitive functioning across the life span","volume":"21","author":"L\u00f6vd\u00e9n","year":"2020","journal-title":"Psychol Sci Public Interest"},{"key":"10.1016\/j.drudis.2026.104665_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101568","article-title":"Pharmacological treatments for psychotic symptoms in dementia: a systematic review with pairwise and network meta-analysis","volume":"75","author":"Huang","year":"2022","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.drudis.2026.104665_b0015","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s40265-022-01701-7","article-title":"Benefits and harms of 'smart drugs' (nootropics) in healthy individuals","volume":"82","author":"Schifano","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.drudis.2026.104665_b0020","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.drudis.2026.104665_b0025","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41583-023-00677-x","article-title":"Basal forebrain cholinergic signalling: development, connectivity and roles in cognition","volume":"24","author":"Ananth","year":"2023","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.drudis.2026.104665_b0030","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/s41586-023-06436-3","article-title":"Platelet factors attenuate inflammation and rescue cognition in ageing","volume":"620","author":"Schroer","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104665_b0035","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3988\/jcn.2021.17.3.376","article-title":"Discontinuation rate of newly prescribed donepezil in Alzheimer\u2019s disease patients in Asia","volume":"17","author":"Park","year":"2021","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.drudis.2026.104665_b0040","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41398-022-02254-9","article-title":"Effectiveness of KarXT (xanomeline-trospium) for cognitive impairment in schizophrenia: post hoc analyses from a randomised, double-blind, placebo-controlled phase 2 study","volume":"12","author":"Sauder","year":"2022","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.drudis.2026.104665_b0045","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13195-025-01798-4","article-title":"Safety, tolerability, pharmacokinetic and pharmacodynamic effects of the muscarinic M(1) positive allosteric modulator VU0467319 for Alzheimer\u2019s disease: a single ascending-dose study in healthy participants","volume":"17","author":"Conley","year":"2025","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.drudis.2026.104665_b0050","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1021\/acschemneuro.4c00769","article-title":"Discovery of VU0467319: an M(1) positive allosteric modulator candidate that advanced into clinical trials","volume":"16","author":"Poslunsey","year":"2025","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.drudis.2026.104665_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107726","article-title":"JWX-A0108, a positive allosteric modulator of \u03b17 nAChR, attenuates cognitive deficits in APP\/PS1 mice by suppressing NF-\u03baB-mediated inflammation","volume":"96","author":"Li","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.drudis.2026.104665_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113338","article-title":"Repeated treatment with alpha 7 nicotinic acetylcholine receptor ligands enhances cognitive processes and stimulates Erk1\/2 and Arc genes in rats","volume":"409","author":"Potasiewicz","year":"2021","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.drudis.2026.104665_b0065","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.cell.2021.02.049","article-title":"Structure and gating mechanism of the \u03b17 nicotinic acetylcholine receptor","volume":"184","author":"Noviello","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2026.104665_b0070","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1124\/jpet.119.263483","article-title":"Pharmacological characterization of the novel and selective \u03b17 nicotinic acetylcholine receptor-positive allosteric modulator BNC375","volume":"373","author":"Wang","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.drudis.2026.104665_b0075","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10928-023-09854-y","article-title":"An exploratory analysis of the performance of methylphenidate regimens based on a PKPD model of dopamine and norepinephrine transporter occupancy","volume":"50","author":"Soufsaf","year":"2023","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.drudis.2026.104665_b0080","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1002\/hbm.25949","article-title":"Cognitive enhancement: effects of methylphenidate, modafinil, and caffeine on latent memory and resting state functional connectivity in healthy adults","volume":"43","author":"Becker","year":"2022","journal-title":"Hum Brain Mapp"},{"key":"10.1016\/j.drudis.2026.104665_b0085","first-page":"304","article-title":"Modulation of cerebellar-cortical connectivity induced by modafinil and its relationship with receptor and transporter expression","volume":"10","author":"Delli Pizzi","year":"2025","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"10.1016\/j.drudis.2026.104665_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.nlm.2022.107625","article-title":"Modafinil ameliorates the decline in pronunciation-related working memory caused by 36-h acute total sleep deprivation: an ERP study","volume":"192","author":"Xu","year":"2022","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.drudis.2026.104665_b0095","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2007.03.015","article-title":"Alpha2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex","volume":"129","author":"Wang","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2026.104665_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.112345","article-title":"Characterization of G\u03b1(s) and G\u03b1(olf) activation by catechol and non-catechol dopamine D1 receptor agonists","volume":"28","author":"Nguyen","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.drudis.2026.104665_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110110","article-title":"MSK1 is required for the experience- and ampakine-dependent enhancement of spatial reference memory and reversal learning and for the induction of Arc and BDNF","volume":"261","author":"Mor\u00e8","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drudis.2026.104665_b0110","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s41398-022-02148-w","article-title":"Central nervous system effects of TAK-653, an investigational alpha-amino-3-hydroxy-5-methyl-4-isoxazole receptor (AMPAR) positive allosteric modulator in healthy volunteers","volume":"12","author":"Dijkstra","year":"2022","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.drudis.2026.104665_b0115","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12883-022-02699-x","article-title":"Memantine for the patients with mild cognitive impairment in Parkinson\u2019s disease: a pharmacological fMRI study","volume":"22","author":"Kawashima","year":"2022","journal-title":"BMC Neurol"},{"key":"10.1016\/j.drudis.2026.104665_b0120","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/npp.2017.295","article-title":"mGluR5 modulation of behavioral and epileptic phenotypes in a mouse model of tuberous sclerosis complex","volume":"43","author":"Kelly","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drudis.2026.104665_b0125","article-title":"Negative allosteric modulation of \u03b15-GABA(A) receptors engages dynamic cortical glutamatergic and GABAergic mechanisms underlying adaptive behavior in mice","volume":"16","author":"Daher","year":"2026","journal-title":"bioRxiv"},{"key":"10.1016\/j.drudis.2026.104665_b0130","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s11689-022-09418-0","article-title":"A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABA(A)-\u03b15 NAM (basmisanil) on intellectual disability associated with down syndrome","volume":"14","author":"Goeldner","year":"2022","journal-title":"J Neurodev Disord"},{"key":"10.1016\/j.drudis.2026.104665_b0135","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1626078","article-title":"Preclinical pharmacology of alogabat: a novel GABA(A)-\u03b15 positive allosteric modulator targeting neurodevelopmental disorders with impaired GABA(A) signaling","volume":"16","author":"Cecere","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.drudis.2026.104665_b0140","article-title":"Electroencephalography biomarkers of \u03b15-GABA positive allosteric modulators in rodents","volume":"5","author":"Mazza","year":"2024","journal-title":"Biol Psychiatry Glob Open Sci"},{"key":"10.1016\/j.drudis.2026.104665_b0145","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.biopsych.2021.11.024","article-title":"Negative allosteric modulation of gamma-aminobutyric acid A receptors at \u03b15 subunit-containing benzodiazepine sites reverses stress-induced anhedonia and weakened synaptic function in mice","volume":"92","author":"Troppoli","year":"2022","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.drudis.2026.104665_b0150","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1306496","article-title":"Aging or chronic stress impairs working memory and modulates GABA and glutamate gene expression in prelimbic cortex","volume":"15","author":"Gandy","year":"2024","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.drudis.2026.104665_b0155","doi-asserted-by":"crossref","DOI":"10.1111\/ejn.70187","article-title":"GABA(B) receptors mediate intracellular calcium release in astrocytes of the prefrontal cortex","volume":"62","author":"Bostel","year":"2025","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.drudis.2026.104665_b0160","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/s41398-021-01754-4","article-title":"Effects of escitalopram therapy on resting-state functional connectivity of subsystems of the default mode network in unmedicated patients with major depressive disorder","volume":"11","author":"Cui","year":"2021","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.drudis.2026.104665_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2021.118110","article-title":"Escitalopram enhances synchrony of brain responses during emotional narratives in patients with major depressive disorder","volume":"237","author":"Komulainen","year":"2021","journal-title":"Neuroimage"},{"key":"10.1016\/j.drudis.2026.104665_b0170","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41386-022-01523-x","article-title":"Chronic escitalopram in healthy volunteers has specific effects on reinforcement sensitivity: a double-blind, placebo-controlled semi-randomised study","volume":"48","author":"Langley","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drudis.2026.104665_b0175","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jad.2024.06.003","article-title":"Cognitive improvement in late-life depression treated with vortioxetine and duloxetine in an eight-week randomized controlled trial: the role of age at first onset and change in depressive symptoms","volume":"361","author":"Xue","year":"2024","journal-title":"J Affect Disord"},{"key":"10.1016\/j.drudis.2026.104665_b0180","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.drudis.2026.104665_b0185","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.35082","article-title":"Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor","volume":"7","author":"Preller","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.drudis.2026.104665_b0190","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","article-title":"Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo","volume":"109","author":"Shao","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.drudis.2026.104665_b0195","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1021\/acschemneuro.1c00181","article-title":"Optimized TrkB agonist ameliorates Alzheimer\u2019s disease pathologies and improves cognitive functions via inhibiting delta-secretase","volume":"12","author":"Chen","year":"2021","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.drudis.2026.104665_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108737","article-title":"Targeting both BDNF\/TrkB pathway and delta-secretase for treating Alzheimer\u2019s disease","volume":"197","author":"Liao","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drudis.2026.104665_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108899","article-title":"Mitochondriomics reveals the underlying neuroprotective mechanism of TrkB receptor agonist R13 in the 5\u00d7FAD mice","volume":"204","author":"Li","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drudis.2026.104665_b0210","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11064-024-04285-8","article-title":"AMP-activated protein kinase treatment ameliorates chronic restraint stress induced memory impairment in early adolescent rat by restoring metabolite profile and synaptic proteins","volume":"50","author":"Rajan","year":"2024","journal-title":"Neurochem Res"},{"key":"10.1016\/j.drudis.2026.104665_b0215","first-page":"1732","article-title":"Long-term improvement in hippocampal-dependent learning ability in healthy, aged individuals following high intensity interval training","volume":"16","author":"Blackmore","year":"2024","journal-title":"Aging Dis"},{"key":"10.1016\/j.drudis.2026.104665_b0220","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13293-023-00499-7","article-title":"Aerobic exercise improves executive functions in females, but not males, without the BDNF Val66Met polymorphism","volume":"14","author":"Barha","year":"2023","journal-title":"Biol Sex Differ"},{"key":"10.1016\/j.drudis.2026.104665_b0225","doi-asserted-by":"crossref","first-page":"25658","DOI":"10.1038\/s41598-025-11098-4","article-title":"The impact of citicoline on brain mitochondrial dysfunction induced in rats after head irradiation","volume":"15","author":"Abdel-Aziz","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2026.104665_b0230","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1093\/jn\/nxab119","article-title":"Citicoline and memory function in healthy older adults: a randomized, double-blind, placebo-controlled clinical trial","volume":"151","author":"Nakazaki","year":"2021","journal-title":"J Nutr"},{"key":"10.1016\/j.drudis.2026.104665_b0235","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.exger.2018.04.013","article-title":"Effects of creatine supplementation on cognitive function of healthy individuals: a systematic review of randomized controlled trials","volume":"108","author":"Avgerinos","year":"2018","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.drudis.2026.104665_b0240","article-title":"Elamipretide (SS-31) improves functional connectivity in hippocampus and other related regions following prolonged neuroinflammation induced by lipopolysaccharide in aged rats","volume":"13","author":"Liu","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.drudis.2026.104665_b0245","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00011-024-01860-1","article-title":"SS-31 inhibits mtDNA-cGAS-STING signaling to improve POCD by activating mitophagy in aged mice","volume":"73","author":"Ji","year":"2024","journal-title":"Inflamm Res"},{"key":"10.1016\/j.drudis.2026.104665_b0250","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neubiorev.2018.02.001","article-title":"The pharmacology of amphetamine and methylphenidate: relevance to the neurobiology of attention-deficit\/hyperactivity disorder and other psychiatric comorbidities","volume":"87","author":"Faraone","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.drudis.2026.104665_b0255","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0924-977X(02)00104-9","article-title":"Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies","volume":"12","author":"Volkow","year":"2002","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.drudis.2026.104665_b0260","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s43440-025-00763-0","article-title":"Current insights into the safety and adverse effects of methylphenidate in children, adolescents, and adults\u2014narrative review","volume":"77","author":"Silczuk","year":"2025","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.drudis.2026.104665_b0265","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1124\/jpet.104.077172","article-title":"Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than n-methyl-D-aspartate receptors in rat hippocampal neurons","volume":"312","author":"Aracava","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.drudis.2026.104665_b0270","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1124\/jpet.104.081976","article-title":"Comments on \u201cMemantine blocks alpha7* nicotinic acetylcholine receptors more potently than N-methyl-D-aspartate receptors in rat hippocampal neurons\u201d","volume":"313","author":"Banerjee","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.drudis.2026.104665_b0275","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyaf014","article-title":"Synergistic effects of memantine and alpha7 nicotinic acetylcholine receptor agonist PHA-543613 to improve memory of aged rats","volume":"28","author":"Bruszt","year":"2025","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.drudis.2026.104665_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175810","article-title":"Targeting \u03b17-nAChR by galantamine mitigates reserpine-induced fibromyalgia-like symptoms in rats: Involvement of cAMP\/PKA, PI3K\/AKT, and M1\/M2 microglia polarization","volume":"952","author":"Atta","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.drudis.2026.104665_b0285","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3390\/biom13050751","article-title":"5-HT6 receptors sex-dependently modulate hippocampal synaptic activity through GABA inhibition","volume":"13","author":"Lahogue","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.drudis.2026.104665_b0290","article-title":"Effect of masupirdine (SUVN-502) on cognition in patients with moderate Alzheimer\u2019s disease: a randomized, double-blind, phase 2, proof-of-concept study","volume":"8","author":"Nirogi","year":"2022","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.drudis.2026.104665_b0295","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s40120-022-00390-4","article-title":"Effect of concurrent use of memantine on the efficacy of masupirdine (SUVN-502): a post hoc analysis of a phase 2 randomized placebo-controlled study","volume":"11","author":"Nirogi","year":"2022","journal-title":"Neurol Ther"},{"key":"10.1016\/j.drudis.2026.104665_b0300","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0140-6736(17)30060-0","article-title":"Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial","volume":"389","author":"N\u00e9meth","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2026.104665_b0305","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.schres.2018.08.020","article-title":"Efficacy of cariprazine on negative symptoms in patients with acute schizophrenia: a post hoc analysis of pooled data","volume":"204","author":"Earley","year":"2019","journal-title":"Schizophr Res"},{"key":"10.1016\/j.drudis.2026.104665_b0310","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1017\/S109285292200013X","article-title":"The efficacy of cariprazine on cognition: a post hoc analysis from phase II\/III clinical trials in bipolar mania, bipolar depression, and schizophrenia","volume":"28","author":"McIntyre","year":"2023","journal-title":"CNS Spectr"},{"key":"10.1016\/j.drudis.2026.104665_b0315","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1016\/j.cell.2025.06.035","article-title":"Cell-type-directed network-correcting combination therapy for Alzheimer\u2019s disease","volume":"188","author":"Li","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2026.104665_b0320","article-title":"Network-based drug repurposing for psychiatric disorders using single-cell genomics","volume":"5","author":"Gupta","year":"2025","journal-title":"Cell Genom"},{"key":"10.1016\/j.drudis.2026.104665_b0325","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1659947","article-title":"The dual nature of neuroinflammation in networked brain","volume":"16","author":"M\u00fcller","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2026.104665_b0330","doi-asserted-by":"crossref","first-page":"8372","DOI":"10.1038\/s41467-025-62405-6","article-title":"CD103(-)CD8(+) T cells promote neurotoxic inflammation in Alzheimer\u2019s disease via granzyme K-PAR-1 signaling","volume":"16","author":"Terrabuio","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104665_b0335","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bbi.2020.07.027","article-title":"Suppression of microglial activation and monocyte infiltration ameliorates cerebellar hemorrhage induced-brain injury and ataxia","volume":"89","author":"Xie","year":"2020","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.drudis.2026.104665_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120346","article-title":"Reconnoitering the transformative journey of minocycline from an antibiotic to an antiepileptic drug","volume":"293","author":"Singh","year":"2022","journal-title":"Life Sci"},{"key":"10.1016\/j.drudis.2026.104665_b0345","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2026.104665_b0350","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41581-021-00430-6","article-title":"Hypertension-induced cognitive impairment: from pathophysiology to public health","volume":"17","author":"Ungvari","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.drudis.2026.104665_b0355","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3390\/antiox10111702","article-title":"Induction of the Nrf2 pathway by sulforaphane is neuroprotective in a rat temporal lobe epilepsy model","volume":"10","author":"Sandouka","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.drudis.2026.104665_b0360","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archneurol.2010.229","article-title":"A randomized pilot clinical trial of the safety of pioglitazone in treatment of patients with Alzheimer disease","volume":"68","author":"Geldmacher","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.drudis.2026.104665_b0365","doi-asserted-by":"crossref","first-page":"7218","DOI":"10.1523\/JNEUROSCI.2574-18.2019","article-title":"Neuroinflammation and functional connectivity in Alzheimer\u2019s disease: interactive influences on cognitive performance","volume":"39","author":"Passamonti","year":"2019","journal-title":"J Neurosci"},{"key":"10.1016\/j.drudis.2026.104665_b0370","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jaad.2019.07.107","article-title":"New ways to learn: enhanced social media and JAAD virtual journal club 1 year later","volume":"82","author":"Altman","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.drudis.2026.104665_b0375","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41556-017-0021-z","article-title":"MSK1 regulates luminal cell differentiation and metastatic dormancy in ER(+) breast cancer","volume":"20","author":"Gawrzak","year":"2018","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.drudis.2026.104665_b0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107410","article-title":"Role of histone deacetylases and their inhibitors in neurological diseases","volume":"208","author":"Zhang","year":"2024","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.drudis.2026.104665_b0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107651","article-title":"Design of multi-target drugs of HDACs and other anti-Alzheimer related targets: current strategies and future prospects in Alzheimer\u2019s diseases therapy","volume":"151","author":"Soltan","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.drudis.2026.104665_b0390","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrd2468","article-title":"Prodrugs: design and clinical applications","volume":"7","author":"Rautio","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.drudis.2026.104665_b0395","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41422-019-0216-x","article-title":"Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer\u2019s disease progression","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Res"},{"key":"10.1016\/j.drudis.2026.104665_b0400","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.3233\/JPD-212813","article-title":"Foslevodopa\/foscarbidopa is well tolerated and maintains stable levodopa and carbidopa exposure following subcutaneous infusion","volume":"11","author":"Rosebraugh","year":"2021","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.drudis.2026.104665_b0405","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.drudis.2018.11.014","article-title":"Artificial intelligence in drug development: present status and future prospects","volume":"24","author":"Mak","year":"2019","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2026.104665_b0410","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/s41587-019-0224-x","article-title":"Deep learning enables rapid identification of potent DDR1 kinase inhibitors","volume":"37","author":"Zhavoronkov","year":"2019","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.drudis.2026.104665_b0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108352","article-title":"Efficacy of acetylcholinesterase inhibitors in Alzheimer\u2019s disease","volume":"190","author":"Marucci","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drudis.2026.104665_b0420","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ibneur.2025.05.016","article-title":"A meta-analysis update evaluating the treatment effects of donepezil alone versus donepezil combined with memantine for Alzheimer\u2019s disease","volume":"19","author":"Hajihosseini","year":"2025","journal-title":"IBRO Neurosci Rep"},{"key":"10.1016\/j.drudis.2026.104665_b0425","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized phase 3 studies of aducanumab in early Alzheimer\u2019s disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.drudis.2026.104665_b0430","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.drudis.2026.104665_b0435","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13195-024-01441-8","article-title":"Updated safety results from phase 3 lecanemab study in early Alzheimer\u2019s disease","volume":"16","author":"Honig","year":"2024","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.drudis.2026.104665_b0440","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/pcn.13812","article-title":"Structural and metabolic topological alterations associated with butylphthalide treatment in mild cognitive impairment: data from a randomized, double-blind, placebo-controlled trial","volume":"79","author":"Han","year":"2025","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.drudis.2026.104665_b0445","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1039\/D2FO03389E","article-title":"Microbial nattokinase: from synthesis to potential application","volume":"14","author":"Sheng","year":"2023","journal-title":"Food Funct"},{"key":"10.1016\/j.drudis.2026.104665_b0450","article-title":"Identification of cerebrospinal fluid pharmacodynamic biomarkers and molecular correlates of brain activity in a phase 2 clinical trial of the Alzheimer\u2019s disease drug candidate CT1812","volume":"11","author":"Di Caro","year":"2025","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.drudis.2026.104665_b0455","doi-asserted-by":"crossref","first-page":"H725","DOI":"10.1152\/ajpheart.00621.2020","article-title":"Cardiac \u03b11A-adrenergic receptors: emerging protective roles in cardiovascular diseases","volume":"320","author":"Zhang","year":"2021","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.drudis.2026.104665_b0460","article-title":"Souvenaid for Alzheimer\u2019s disease","volume":"12","author":"Burckhardt","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.drudis.2026.104665_b0465","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40780-015-0014-7","article-title":"Meta-analysis of the efficacy and safety of Ginkgo biloba extract for the treatment of dementia","volume":"1","author":"Hashiguchi","year":"2015","journal-title":"J Pharm Health Care Sci"},{"key":"10.1016\/j.drudis.2026.104665_b0470","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1162\/jocn_a_00776","article-title":"Prescription stimulants\u2019 effects on healthy inhibitory control, working memory, and episodic memory: a meta-analysis","volume":"27","author":"Ilieva","year":"2015","journal-title":"J Cogn Neurosci"},{"key":"10.1016\/j.drudis.2026.104665_b0475","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3390\/brainsci13091335","article-title":"A systematic review and meta-analysis of cognitive effects of rTMS in Caucasian patients with mild cognitive impairment","volume":"13","author":"Licht","year":"2023","journal-title":"Brain Sci"},{"key":"10.1016\/j.drudis.2026.104665_b0480","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.drudis.2026.104665_b0485","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","article-title":"TREM2 maintains microglial metabolic fitness in Alzheimer\u2019s disease","volume":"170","author":"Ulland","year":"2017","journal-title":"Cell"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135964462600070X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135964462600070X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T16:16:28Z","timestamp":1785946588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135964462600070X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":97,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S135964462600070X"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104665","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cognition-enhancing drugs: current landscape, mechanisms, and future prospects","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104665","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104665"}}